CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 40 enrolled
Drug / intervention
Transcranial Direct Current Stimulation (tDCS)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03351426
NCT03351426Phase 2Completed
CompareCT.gov

Neuromodulation With Transcranial Direct Current Stimulation (tDCS) to Control Excess Weight

University of Alcala·interventional·Posted Nov 22, 2017·Updated Aug 22, 2018

In Brief

A Phase 2 clinical trial evaluating Transcranial Direct Current Stimulation (tDCS) for Overweight and Obesity. Completed, enrolled 40 participants across 1 site.

Detailed Summary

The purpose of this study is to examine the effects of noninvasive neuromodulation with transcranial direct current stimulation (tDCS) aimed at enhancing the excitability of the left prefrontal cortex in middle-aged women with excess body weight. This is a randomized, parallel, double-blind study with a duration of 4 weeks. Outcome measures will include changes in performance in a computerized task assessing executive functions, subjective measures of food craving and appetite and changes in body weight.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOverweight and Obesity
CountriesSpain
Collaborators--

Timeline

Phase 2CompletedFinished
2017201820192020202120222023202420252026
First PostedNov 22, 2017
Enrollment StartSep 1, 2016
Primary CompletionMay 1, 2018
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 8.6 years ago

Interventions

Transcranial Direct Current Stimulation (tDCS)device

Transcranial Direct Current Stimulation (tDCS) is a noninvasive form of neuromodulation that uses constant, low-intensity direct current delivered via electrodes that are placed on the head.